A potential prodrug for a green tea polyphenol proteasome inhibitor: evaluation of the peracetate ester of (-)-epigallocatechin gallate [(-)-EGCG]

被引:113
作者
Lam, WH
Kazi, A
Kuhn, DJ
Chow, LMC
Chan, ASC
Dou, QP
Chan, TH [1 ]
机构
[1] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Hong Kong, Hong Kong, Peoples R China
[2] Hong Kong Polytech Univ, Open Lab Chiral Technol, Inst Mol Technol Drug Discovery & Synth, Hong Kong, Hong Kong, Peoples R China
[3] Wayne State Univ, Prevent Program, Barbara Ann Karmanos Canc Inst, Detroit, MI 48201 USA
[4] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA
关键词
D O I
10.1016/j.bmc.2004.08.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Green tea has been shown to have many biological effects, including effects on metabolism, angiogenesis, oxidation, and cell proliferation. Unfortunately, the most abundant green tea polyphenol (-)-epigallocatechin gallate or (-)-EGCG is very unstable in neutral or alkaline medium. This instability leads to a low bioavailability. In an attempt to enhance the stability of (-)-EGCG, we introduced peracetate protection groups on the reactive hydroxyls of (-)-EGCG (noted in text as 1). HPLC analysis shows that the protected (-)-EGCG analog is six times more stable than natural (-)-EGCG under slightly alkaline conditions. A series of bioassays show that 1 has no inhibitory activity against a purified 20S proteasome in vitro, but exhibits increased proteasome-inhibitory activity in intact leukemic cells over natural (-)-EGCG, indicating an intercellular conversion. Inhibition of cellular proteasome activity by 1 is associated with induction of cell death. Therefore, our results indicate that the protected analog 1 may function as a prodrug of the green tea polyphenol proteasome inhibitor (-)-EGCG. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5587 / 5593
页数:7
相关论文
共 31 条
[1]   Novel dipeptidyl proteasome inhibitors overcome Bcl-2 protective function and selectively accumulate the cyclin-dependent kinase inhibitor p27 and induce apoptosis in transformed, but not normal, human fibroblasts [J].
An, B ;
Goldfarb, RH ;
Siman, R ;
Dou, QP .
CELL DEATH AND DIFFERENTIATION, 1998, 5 (12) :1062-1075
[2]   The chemistry of tea flavonoids [J].
Balentine, DA ;
Wiseman, SA ;
Bouwens, LCM .
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION, 1997, 37 (08) :693-704
[3]   The proteasome:: Paradigm of a self-compartmentalizing protease [J].
Baumeister, W ;
Walz, J ;
Zühl, F ;
Seemuller, E .
CELL, 1998, 92 (03) :367-380
[4]   Proteasome inhibitors as potential novel anticancer agents [J].
Dou, QP ;
Li, BY .
DRUG RESISTANCE UPDATES, 1999, 2 (04) :215-223
[5]   Two stages of cancer prevention with green tea [J].
Fujiki, H .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1999, 125 (11) :589-597
[6]   FUNCTIONS OF THE PROTEASOME - THE LYSIS AT THE END OF THE TUNNEL [J].
GOLDBERG, AL .
SCIENCE, 1995, 268 (5210) :522-523
[7]   Structure of 20S proteasome from yeast at 2.4 angstrom resolution [J].
Groll, M ;
Ditzel, L ;
Lowe, J ;
Stock, D ;
Bochtler, M ;
Bartunik, HD ;
Huber, R .
NATURE, 1997, 386 (6624) :463-471
[8]  
Haslam E., 1989, PLANT POLYPHENOLS VE
[9]   The active sites of the eukaryotic 20 S proteasome and their involvement in subunit precursor processing [J].
Heinemeyer, W ;
Fischer, M ;
Krimmer, T ;
Stachon, U ;
Wolf, DH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (40) :25200-25209
[10]   UBIQUITIN, PROTEASOMES, AND THE REGULATION OF INTRACELLULAR PROTEIN-DEGRADATION [J].
HOCHSTRASSER, M .
CURRENT OPINION IN CELL BIOLOGY, 1995, 7 (02) :215-223